Project courses at IGP are offered as 7.5, 15 or 30 credit courses.
For students interested in these courses:
Please apply by filling in the Project Agreement. Note that you have to agree on a project with your supervisor to be eligible for the course. Apply for the course at antagning.se. Do not forget to upload the filled form with your application. Here you can find help how to apply.
If you - as a supervisor - accept a project student or intern, please follow the instructions outlined in the Procedure for student projects and unpaid internships at IGP, before the person is registered in Columbus.
Projects in the research area cancer/oncology
In our projects we incorporate experience of neural stem cells with glioma biology, leveraging the close relationship between these two fields. We focus on the tumor microenvironment with special emphasis on the extracellular matrix and the neuro-inflammatory responses to brain tumors.
We are looking for students interested in improving treatment and diagnostics for cancer through bioinformatic analyses of molecular data.
We are looking for motivated students that want to develop their skills in laboratory work centered on drug screening in cell and organoid models, or students that want to work with bioinformatic analysis to search for new potential targets to study.
The EphB receptors and their ligands have been shown to have both proliferation promoting and tumor suppressing roles. Here, we use cancer cell models to study how EPHB2 mutations affect colorectal cancer progression.
Machine learning and computer vision is gaining traction in clinical radiology. We are looking for students to participate in model development and building of different automated pipelines for clinical radiology tasks.
Opportunity for students to work with clinical data or sample analyses based on the cancer cases included in U-CAN.
We are looking for students that want to participate in analysis of large-scale omics data to find and validate cancer biomarkers.
The lymph nodes have essential roles in adaptive immune responses, including antitumour immune responses, and are major sites for tumour metastasis. Our group is interested in the stromal changes that occur in the tumour draining lymph nodes and particularly the changes of the vasculature and how this affect tumour metastasis and anti-tumour immune responses.
Multiple myeloma (MM) despite becoming increasingly treatable remains to date incurable and accounts for the second most common hematological cancer. This warrants innovative approaches into tackling the disease overtly complex genetic background. Our research aims is to identify interacting partners with the Polycomb group proteins by RNA immunoprecipitation coupled with next generation sequencing (RIP-seq, CLIP seq or iCLIP) in MM cell lines and primary MM samples. We also aim to identify the genome-specific binding of lncRNAs of interest by chromatin isolation via RNA precipitation (ChIRP) assays coupled to next generation sequencing and mass spectrometry.
Glioblastoma is the most common and deadly primary brain cancer. Our research aims at identifying mechanisms governing progression and recurrence, with focus on the cancer stem cells. We use patient-‐derived cell cultures and mouse models, and the goal is to find novel therapeutic targets in glioblastoma.
Lysosomes are acidic organelles that degrade macromolecules and have often been viewed as basic “trashcans” of cells. In recent years however, it has become clear that lysosomes function as crucial gate-keepers of cell growth and cancer. This is largely due to the surprising finding that the principal regulators of anabolic metabolism specifically locate to the lysosomal surface (1,2,3). An aberrant increase in lysosome number and abundance frequently accompanies malignant cells (4), yet it remains unclear how these changes rewire anabolic metabolism and the growth-potential of cancer cells
New treatment for glioblastoma: Regulation of general resistance mechanisms and opportunities for development of new therapeutic protocols.
Glioblastoma multiforme (GBM) is the most malignant primary brain tumor. The cancer cells vary between more treatment-resistant and more treatment-sensitive cell-states. Current studies aim to uncover forces that drives these phenotypically linked cell-state transitions changes to develop efficient treatment.
Projects in the research area vascular biology
In this project, you will test a library of chemical compounds on zebrafish embryos. Depending on the length of the project, you will perform the pre-screening for toxicity and chemical screens for a number of these compounds. You will acquire competences in zebrafish handling, chemical screen methodology and confocal microscopy.
Zebrafish is an excellent model for fast and efficient generation of tissue specific transgenic reporters. In our lab we have generated a dataset of candidate gene regulatory elements that drive vascular specific gene expression. In this project you will have the opportunity to generate and test constructs for transgenesis. This will validate if the predicted sequences indeed drive the fluorescent expression in correct tissue.
Projects in the research area Molecular Tools
Molecular diagnostics will increasingly impact medical practice. Our group develops, applies, and commercializes advanced molecular tools for diagnostic analyses of nucleic acids and proteins in situ and in solution. We welcome students interested in medical applications of the methods.
Projects in the research area Genetics and Genomics
Neurodevelopmental and neurodegenerative disorders comprise a heterogeneous group of conditions for which treatment options are limited. Our group develops cell models of central nervous system disorders using induced pluripotent stem cells (iPSC). The long-term objective is to identify disease biomarkers that can be used for rescue-screens in search for candidate compounds and drug development.